Benzamide
CAS No. 55-21-0
Benzamide( —— )
Catalog No. M18793 CAS No. 55-21-0
Benzamide, an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 50MG | 28 | In Stock |
|
| 100MG | 37 | In Stock |
|
| 200MG | 52 | In Stock |
|
| 500MG | 86 | In Stock |
|
| 1G | 124 | In Stock |
|
Biological Information
-
Product NameBenzamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzamide, an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic acid.
-
DescriptionBenzamide, an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic acid.
-
In Vitro——
-
In VivoBenzamide (160 mg/kg; IP, 2 injection by a 4 h interval) attenuates the METH-induced dopamine depletions.Benzamide (160 mg/kg; IP, single dosage) has no acute effect on striatal dopamine metabolism and does not reduce body temperature. Animal Model:C57B1/6N mice (intraperitoneal injection of METH at 2-h intervals; 4 injections of 5 mg/kg, 4 injections of 10 mg/kg, or 2 injections of 20 mg/kg) Dosage:160 mg/kg Administration:IP, 2 injection by a 4 h interval Result:Partially and significantly attenuated the METH-induced dopamine depletions during the different METH treatment.Animal Model:C57B1/6N mice Dosage:160 mg/kg Administration:IP, single dosage Result:Had no acute effect on striatal dopamine metabolism and did not reduce body temperature.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPARP
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number55-21-0
-
Formula Weight121.14
-
Molecular FormulaC7H7NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 120 mg/mL (990.59 mM)
-
SMILESC1=CC=C(C=C1)C(=O)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
Glycyrrhizin-6,6-dim...
Glycyrrhizin-6′,6′′-dimethylester (compound 23) is a licorice saponin isolated from licorice root. Glycyrrhizin-6′,6′′-dimethylester can participate as an aglycone in the generation of methyl glucuronate, producing similar threshold sweetness, licorice, and bitterness.
-
Carbobenzoxyphenylal...
Carbobenzoxyphenylalanine is a thermolysin inhibitor.The protease can be inhibited by the serine specific reagents phenylmethanesulfonyl fluoride and diisopropyl fluorophosphate and the alkylating reagent, carbobenzoxyphenylalanine chloromethyl ketone, in the presence of organic solvents at 1 mM concentration.?
Cart
sales@molnova.com